Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial.

K A Margolin; P Y Liu; J M Unger; W S Fletcher; L E Flaherty; W J Urba; E M Hersh; L E Hutchins; J A Sosman; J W Smith

doi:10.1007/s004320050276

Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial.

Identifier:nobleid.org/w1/20260515/5EB6DF24

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5EB6DF24.svg?ark=w1%2F20260515%2F5EB6DF24)](https://nobleid.org/work/w1/20260515/5EB6DF24)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial.

Identifier:nobleid.org/w1/20260515/5EB6DF24

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5EB6DF24.svg?ark=w1%2F20260515%2F5EB6DF24)](https://nobleid.org/work/w1/20260515/5EB6DF24)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work